The Nuclear Pore and XPO1: Guardian of the Genome

The Nuclear Pore and XPO1: Guardian of the Genome

September 15, 2020
1:30pm (EST) 

In this webinar, you will hear from Karyopharm’s Founder, President and Chief Scientific Officer and other renowned subject matter experts on the incredible biology around the nuclear pore complex, including the nuclear export of key proteins via XPO1 and the unique mechanism of action of our lead compound, XPOVIO® (selinexor). Learn how the regulation and location of key proteins in-and-out of the cell’s nucleus can have such a profound impact across so many different disease areas.